Platelet Rich Plasma-Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Platelet Rich Plasma market is accounted for $476.10 million in 2020 and is expected to reach $1,358.12 million by 2028 growing at a CAGR 14.0% during the forecast period. The rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areas and increase in the number of orthopaedic surgeries & sports injuries are the major factors driving the market growth. However, high cost of the treatment is restraining the market growth.
Platelet rich plasma (PRP) is derived from blood, extractor to remove red blood cells and is also known as platelet rich gel, platelet enriched plasma, platelet enriched gel and autologous conditioned plasma. It is produced when the human blood is turned down and the platelet rich plasma gets separate that have a concentration of platelets above the normal values. It aid in blood thickening and also to boost the ligaments, healing of muscles. PRP is extremely rich in healing factors and connective tissue growth. It combines modern technology with body’s own ability to rebuild itself. PRP therapy has an extensive application in cosmetic industry.
Based on product type, the leukocyte rich platelet rich plasma (L-PRP) segment is estimated to have a lucrative growth, due to the potential risks associated with leukocyte rich PRP, this market space is witnessing a significant increase in the commercial pool and number of experimental systems and expanding potential applications across orthopedic, general surgery, and sports medicine. By geography, North America is going to have high growth during forecast period due to rising incidence of orthopedic diseases, rise in demand for cosmetic surgeries along with the approvals of various products by the U.S. FDA and growing awareness amongst the patient population in this particular region.
Some of the key players profiled in the Platelet Rich Plasma Market include AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, Glofinn Oy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, Arthrex Inc, Stryker Exactech Inc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC, Zimmer Biomet Company.
Product Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Platelet rich plasma (PRP) is derived from blood, extractor to remove red blood cells and is also known as platelet rich gel, platelet enriched plasma, platelet enriched gel and autologous conditioned plasma. It is produced when the human blood is turned down and the platelet rich plasma gets separate that have a concentration of platelets above the normal values. It aid in blood thickening and also to boost the ligaments, healing of muscles. PRP is extremely rich in healing factors and connective tissue growth. It combines modern technology with body’s own ability to rebuild itself. PRP therapy has an extensive application in cosmetic industry.
Based on product type, the leukocyte rich platelet rich plasma (L-PRP) segment is estimated to have a lucrative growth, due to the potential risks associated with leukocyte rich PRP, this market space is witnessing a significant increase in the commercial pool and number of experimental systems and expanding potential applications across orthopedic, general surgery, and sports medicine. By geography, North America is going to have high growth during forecast period due to rising incidence of orthopedic diseases, rise in demand for cosmetic surgeries along with the approvals of various products by the U.S. FDA and growing awareness amongst the patient population in this particular region.
Some of the key players profiled in the Platelet Rich Plasma Market include AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, Glofinn Oy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, Arthrex Inc, Stryker Exactech Inc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC, Zimmer Biomet Company.
Product Types Covered:
- Instruments
- Leukocyte Rich Platelet Rich Plasma (L-PRP)
- Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
- Platelet Rich Plasma (PRP) Gel
- Pure Platelet Rich Plasma (P-PRP)
- Pure Platelet-Rich Fibrin (P-PRF)
- Autologous
- Allogeneic
- Homologous
- Sports Medicine
- Cosmetic Surgery and Dermatology
- Orthopedic/Spinal Surgery
- Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General Surgery
- Dentistry
- Cardiac Muscle Injury
- Nerve Injury
- Periodontal Surgery
- Aesthetics
- Other Applications
- Platelet-Derived Growth Factor (PDGF)
- Vascular Endothelial Growth Factor (VEGF)
- Epidermal Growth Factor (EGF)
- Fibroblast Growth Factor-2 (FGF-2)
- Insulin-like Growth Factor (IGF)
- Hospitals & Clinics
- Academic & Research Institutes
- Orthopedic Clinics
- Cosmetic/Dermatology/Trichology Clinics
- Physician's office/Private Practice
- Ophthalmic Clinics
- Manufacturer/Distributor/Service Provider
- Aftermarket
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years (2019, 2020, 2021, 2025, and 2028)
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of COVID
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining Power Of Suppliers
4.2 Bargaining Power Of Buyers
4.3 Threat Of Substitutes
4.4 Threat Of New Entrants
4.5 Competitive Rivalry
5 GLOBAL PLATELET RICH PLASMA MARKET, BY PRODUCT TYPE
5.1 Introduction
5.2 Instruments
5.3 Leukocyte Rich Platelet Rich Plasma (L-PRP)
5.4 Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
5.5 Platelet Rich Plasma (PRP) Gel
5.6 Pure Platelet Rich Plasma (P-PRP)
5.7 Pure Platelet-Rich Fibrin (P-PRF)
6 GLOBAL PLATELET RICH PLASMA MARKET, BY SOURCE /ORIGIN
6.1 Introduction
6.2 Autologous
6.3 Allogeneic
6.4 Homologous
7 GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION
7.1 Introduction
7.2 Sports Medicine
7.3 Cosmetic Surgery and Dermatology
7.3.1 Skin Care
7.3.2 Hair Care
7.4 Orthopedic and Spinal Surgery
7.4.1 Arthritis
7.4.2 Chronic Tendinitis
7.4.3 Bone Repair and Regeneration
7.5 Dermatology
7.5.1 Androgenic Alopecia
7.5.2 Plastic Surgery
7.5.3 Cardiac Muscle Injury
7.5.4 Dental
7.5.5 Nerve Injury
7.5.6 Ulcer Healing
7.5.6.1 Venous Ulcer
7.5.6.2 Traumatic Ulcer
7.5.6.3 Diabetic Ulcer
7.5.6.4 Pyoderma Gangrenosum Ulcer
7.5.6.5 Trophic Ulcer
7.5.6.6 Vasculitic Ulcer
7.6 Ophthalmic Surgery
7.7 Neurosurgery
7.8 General Surgery
7.9 Dentistry
7.10 Cardiac Muscle Injury
7.11 Nerve Injury
7.12 Periodontal Surgery
7.13 Aesthetics
7.14 Other Applications
7.14.1 Otorhinolaryngology-Head and Neck Surgery
7.14.2 Oral and Maxillofacial Surgery
7.14.3 Periodontal Surgery
7.14.4 Urology
7.14.5 Cardiothoracic Surgery
8 GLOBAL PLATELET RICH PLASMA MARKET, BY GROWTH FACTOR MOLECULES
8.1 Introduction
8.2 Platelet-Derived Growth Factor (PDGF)
8.3 Vascular Endothelial Growth Factor (VEGF)
8.4 Epidermal Growth Factor (EGF)
8.5 Fibroblast Growth Factor-2 (FGF-2)
8.6 Insulin-like Growth Factor (IGF)
9 GLOBAL PLATELET RICH PLASMA MARKET, BY END USER
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Academic & Research Institutes
9.4 Orthopedic Clinics
9.5 Cosmetic/Dermatology/Trichology Clinics
9.6 Physician's office/Private Practice
9.7 Ophthalmic Clinics
10 GLOBAL PLATELET RICH PLASMA MARKET, BY SALES CHANNEL
10.1 Introduction
10.2 Manufacturer/Distributor/Service Provider
10.3 Aftermarket
11 GLOBAL PLATELET RICH PLASMA MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 KEY DEVELOPMENTS
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 COMPANY PROFILING
13.1 AdiStem Ltd
13.2 Arthrex Inc
13.3 DePuy Synthes Companies (Johnson & Johnson)
13.4 Dr. PRP USA LLC
13.5 EmCyte Corporation
13.6 Glofinn Oy
13.7 Immer Biomet Holdings Inc
13.8 ISTO Biologics
13.9 Regen Lab, Arthrex Inc
13.10 Stryker Exactech Inc
13.11 T-Biotechnology
13.12 ThermoGenesis Holdings Inc
13.13 Vertical Spine LLC
13.14 Zimmer Biomet
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of COVID
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining Power Of Suppliers
4.2 Bargaining Power Of Buyers
4.3 Threat Of Substitutes
4.4 Threat Of New Entrants
4.5 Competitive Rivalry
5 GLOBAL PLATELET RICH PLASMA MARKET, BY PRODUCT TYPE
5.1 Introduction
5.2 Instruments
5.3 Leukocyte Rich Platelet Rich Plasma (L-PRP)
5.4 Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
5.5 Platelet Rich Plasma (PRP) Gel
5.6 Pure Platelet Rich Plasma (P-PRP)
5.7 Pure Platelet-Rich Fibrin (P-PRF)
6 GLOBAL PLATELET RICH PLASMA MARKET, BY SOURCE /ORIGIN
6.1 Introduction
6.2 Autologous
6.3 Allogeneic
6.4 Homologous
7 GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION
7.1 Introduction
7.2 Sports Medicine
7.3 Cosmetic Surgery and Dermatology
7.3.1 Skin Care
7.3.2 Hair Care
7.4 Orthopedic and Spinal Surgery
7.4.1 Arthritis
7.4.2 Chronic Tendinitis
7.4.3 Bone Repair and Regeneration
7.5 Dermatology
7.5.1 Androgenic Alopecia
7.5.2 Plastic Surgery
7.5.3 Cardiac Muscle Injury
7.5.4 Dental
7.5.5 Nerve Injury
7.5.6 Ulcer Healing
7.5.6.1 Venous Ulcer
7.5.6.2 Traumatic Ulcer
7.5.6.3 Diabetic Ulcer
7.5.6.4 Pyoderma Gangrenosum Ulcer
7.5.6.5 Trophic Ulcer
7.5.6.6 Vasculitic Ulcer
7.6 Ophthalmic Surgery
7.7 Neurosurgery
7.8 General Surgery
7.9 Dentistry
7.10 Cardiac Muscle Injury
7.11 Nerve Injury
7.12 Periodontal Surgery
7.13 Aesthetics
7.14 Other Applications
7.14.1 Otorhinolaryngology-Head and Neck Surgery
7.14.2 Oral and Maxillofacial Surgery
7.14.3 Periodontal Surgery
7.14.4 Urology
7.14.5 Cardiothoracic Surgery
8 GLOBAL PLATELET RICH PLASMA MARKET, BY GROWTH FACTOR MOLECULES
8.1 Introduction
8.2 Platelet-Derived Growth Factor (PDGF)
8.3 Vascular Endothelial Growth Factor (VEGF)
8.4 Epidermal Growth Factor (EGF)
8.5 Fibroblast Growth Factor-2 (FGF-2)
8.6 Insulin-like Growth Factor (IGF)
9 GLOBAL PLATELET RICH PLASMA MARKET, BY END USER
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Academic & Research Institutes
9.4 Orthopedic Clinics
9.5 Cosmetic/Dermatology/Trichology Clinics
9.6 Physician's office/Private Practice
9.7 Ophthalmic Clinics
10 GLOBAL PLATELET RICH PLASMA MARKET, BY SALES CHANNEL
10.1 Introduction
10.2 Manufacturer/Distributor/Service Provider
10.3 Aftermarket
11 GLOBAL PLATELET RICH PLASMA MARKET, BY GEOGRAPHY
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 KEY DEVELOPMENTS
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 COMPANY PROFILING
13.1 AdiStem Ltd
13.2 Arthrex Inc
13.3 DePuy Synthes Companies (Johnson & Johnson)
13.4 Dr. PRP USA LLC
13.5 EmCyte Corporation
13.6 Glofinn Oy
13.7 Immer Biomet Holdings Inc
13.8 ISTO Biologics
13.9 Regen Lab, Arthrex Inc
13.10 Stryker Exactech Inc
13.11 T-Biotechnology
13.12 ThermoGenesis Holdings Inc
13.13 Vertical Spine LLC
13.14 Zimmer Biomet
LIST OF TABLES
Table 1 Global Platelet Rich Plasma Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Platelet Rich Plasma Market Outlook, By Product Type (2019-2028) (US $MN)
Table 3 Global Platelet Rich Plasma Market Outlook, By Instruments (2019-2028) (US $MN)
Table 4 Global Platelet Rich Plasma Market Outlook, By Leukocyte Rich Platelet Rich Plasma (L-PRP) (2019-2028) (US $MN)
Table 5 Global Platelet Rich Plasma Market Outlook, By Leukocyte-Rich Platelet Rich Fibrin (L-PRF) (2019-2028) (US $MN)
Table 6 Global Platelet Rich Plasma Market Outlook, By Platelet Rich Plasma (PRP) Gel (2019-2028) (US $MN)
Table 7 Global Platelet Rich Plasma Market Outlook, By Pure Platelet Rich Plasma (P-PRP) (2019-2028) (US $MN)
Table 8 Global Platelet Rich Plasma Market Outlook, By Pure Platelet-Rich Fibrin (P-PRF) (2019-2028) (US $MN)
Table 9 Global Platelet Rich Plasma Market Outlook, By Source /Origin (2019-2028) (US $MN)
Table 10 Global Platelet Rich Plasma Market Outlook, By Autologous (2019-2028) (US $MN)
Table 11 Global Platelet Rich Plasma Market Outlook, By Allogeneic (2019-2028) (US $MN)
Table 12 Global Platelet Rich Plasma Market Outlook, By Homologous (2019-2028) (US $MN)
Table 13 Global Platelet Rich Plasma Market Outlook, By Application (2019-2028) (US $MN)
Table 14 Global Platelet Rich Plasma Market Outlook, By Sports Medicine (2019-2028) (US $MN)
Table 15 Global Platelet Rich Plasma Market Outlook, By Cosmetic Surgery and Dermatology (2019-2028) (US $MN)
Table 16 Global Platelet Rich Plasma Market Outlook, By Skin Care (2019-2028) (US $MN)
Table17 Global Platelet Rich Plasma Market Outlook, By Hair Care (2019-2028) (US $MN)
Table 18 Global Platelet Rich Plasma Market Outlook, By Orthopedic and Spinal Surgery (2019-2028) (US $MN)
Table 19 Global Platelet Rich Plasma Market Outlook, By Arthritis (2019-2028) (US $MN)
Table 20 Global Platelet Rich Plasma Market Outlook, By Chronic Tendinitis (2019-2028) (US $MN)
Table 21 Global Platelet Rich Plasma Market Outlook, By Bone Repair and Regeneration (2019-2028) (US $MN)
Table 22 Global Platelet Rich Plasma Market Outlook, By Dermatology (2019-2028) (US $MN)
Table 23 Global Platelet Rich Plasma Market Outlook, By Androgenic Alopecia (2019-2028) (US $MN)
Table 24 Global Platelet Rich Plasma Market Outlook, By Plastic Surgery (2019-2028) (US $MN)
Table 25 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)
Table 26 Global Platelet Rich Plasma Market Outlook, By Dental (2019-2028) (US $MN)
Table 27 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)
Table 28 Global Platelet Rich Plasma Market Outlook, By Ulcer Healing (2019-2028) (US $MN)
Table 29 Global Platelet Rich Plasma Market Outlook, By Venous Ulcer (2019-2028) (US $MN)
Table 30 Global Platelet Rich Plasma Market Outlook, By Traumatic Ulcer (2019-2028) (US $MN)
Table 31 Global Platelet Rich Plasma Market Outlook, By Diabetic Ulcer (2019-2028) (US $MN)
Table 32 Global Platelet Rich Plasma Market Outlook, By Pyoderma Gangrenosum Ulcer (2019-2028) (US $MN)
Table 33 Global Platelet Rich Plasma Market Outlook, By Trophic Ulcer (2019-2028) (US $MN)
Table 34 Global Platelet Rich Plasma Market Outlook, By Vasculitic Ulcer (2019-2028) (US $MN)
Table 35 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Surgery (2019-2028) (US $MN)
Table 36 Global Platelet Rich Plasma Market Outlook, By Neurosurgery (2019-2028) (US $MN)
Table 37 Global Platelet Rich Plasma Market Outlook, By General Surgery (2019-2028) (US $MN)
Table 38 Global Platelet Rich Plasma Market Outlook, By Dentistry (2019-2028) (US $MN)
Table 39 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)
Table 40 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)
Table 41 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)
Table 42 Global Platelet Rich Plasma Market Outlook, By Aesthetics (2019-2028) (US $MN)
Table 43 Global Platelet Rich Plasma Market Outlook, By Others Application (2019-2028) (US $MN)
Table 44 Global Platelet Rich Plasma Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2019-2028) (US $MN)
Table 45 Global Platelet Rich Plasma Market Outlook, By Oral and Maxillofacial Surgery (2019-2028) (US $MN)
Table 46 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)
Table 47 Global Platelet Rich Plasma Market Outlook, By Urology (2019-2028) (US $MN)
Table 48 Global Platelet Rich Plasma Market Outlook, By Cardiothoracic Surgery (2019-2028) (US $MN)
Table 49 Global Platelet Rich Plasma Market Outlook, By Growth Factor Molecules (2019-2028) (US $MN)
Table 50 Global Platelet Rich Plasma Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2019-2028) (US $MN)
Table 51 Global Platelet Rich Plasma Market Outlook, By Vascular Endothelial Growth Factor (VEGF) (2019-2028) (US $MN)
Table 52 Global Platelet Rich Plasma Market Outlook, By Epidermal Growth Factor (EGF) (2019-2028) (US $MN)
Table 53 Global Platelet Rich Plasma Market Outlook, By Fibroblast Growth Factor-2 (FGF-2) (2019-2028) (US $MN)
Table 54 Global Platelet Rich Plasma Market Outlook, By Insulin-like Growth Factor (IGF) (2019-2028) (US $MN)
Table 55 Global Platelet Rich Plasma Market Outlook, By End User (2019-2028) (US $MN)
Table 56 Global Platelet Rich Plasma Market Outlook, By Hospitals & Clinics (2019-2028) (US $MN)
Table 57 Global Platelet Rich Plasma Market Outlook, By Academic & Research Institutes (2019-2028) (US $MN)
Table 58 Global Platelet Rich Plasma Market Outlook, By Orthopedic Clinics (2019-2028) (US $MN)
Table 59 Global Platelet Rich Plasma Market Outlook, By Cosmetic/Dermatology/Trichology Clinics (2019-2028) (US $MN)
Table 60 Global Platelet Rich Plasma Market Outlook, By Physician's office/Private Practice (2019-2028) (US $MN)
Table 61 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Clinics (2019-2028) (US $MN)
Table 62 Global Platelet Rich Plasma Market Outlook, By Sales Channel (2019-2028) (US $MN)
Table 63 Global Platelet Rich Plasma Market Outlook, By Manufacturer/Distributor/Service Provider (2019-2028) (US $MN)
Table 64 Global Platelet Rich Plasma Market Outlook, By Aftermarket (2019-2028) (US $MN)
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
'
Table 1 Global Platelet Rich Plasma Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Platelet Rich Plasma Market Outlook, By Product Type (2019-2028) (US $MN)
Table 3 Global Platelet Rich Plasma Market Outlook, By Instruments (2019-2028) (US $MN)
Table 4 Global Platelet Rich Plasma Market Outlook, By Leukocyte Rich Platelet Rich Plasma (L-PRP) (2019-2028) (US $MN)
Table 5 Global Platelet Rich Plasma Market Outlook, By Leukocyte-Rich Platelet Rich Fibrin (L-PRF) (2019-2028) (US $MN)
Table 6 Global Platelet Rich Plasma Market Outlook, By Platelet Rich Plasma (PRP) Gel (2019-2028) (US $MN)
Table 7 Global Platelet Rich Plasma Market Outlook, By Pure Platelet Rich Plasma (P-PRP) (2019-2028) (US $MN)
Table 8 Global Platelet Rich Plasma Market Outlook, By Pure Platelet-Rich Fibrin (P-PRF) (2019-2028) (US $MN)
Table 9 Global Platelet Rich Plasma Market Outlook, By Source /Origin (2019-2028) (US $MN)
Table 10 Global Platelet Rich Plasma Market Outlook, By Autologous (2019-2028) (US $MN)
Table 11 Global Platelet Rich Plasma Market Outlook, By Allogeneic (2019-2028) (US $MN)
Table 12 Global Platelet Rich Plasma Market Outlook, By Homologous (2019-2028) (US $MN)
Table 13 Global Platelet Rich Plasma Market Outlook, By Application (2019-2028) (US $MN)
Table 14 Global Platelet Rich Plasma Market Outlook, By Sports Medicine (2019-2028) (US $MN)
Table 15 Global Platelet Rich Plasma Market Outlook, By Cosmetic Surgery and Dermatology (2019-2028) (US $MN)
Table 16 Global Platelet Rich Plasma Market Outlook, By Skin Care (2019-2028) (US $MN)
Table17 Global Platelet Rich Plasma Market Outlook, By Hair Care (2019-2028) (US $MN)
Table 18 Global Platelet Rich Plasma Market Outlook, By Orthopedic and Spinal Surgery (2019-2028) (US $MN)
Table 19 Global Platelet Rich Plasma Market Outlook, By Arthritis (2019-2028) (US $MN)
Table 20 Global Platelet Rich Plasma Market Outlook, By Chronic Tendinitis (2019-2028) (US $MN)
Table 21 Global Platelet Rich Plasma Market Outlook, By Bone Repair and Regeneration (2019-2028) (US $MN)
Table 22 Global Platelet Rich Plasma Market Outlook, By Dermatology (2019-2028) (US $MN)
Table 23 Global Platelet Rich Plasma Market Outlook, By Androgenic Alopecia (2019-2028) (US $MN)
Table 24 Global Platelet Rich Plasma Market Outlook, By Plastic Surgery (2019-2028) (US $MN)
Table 25 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)
Table 26 Global Platelet Rich Plasma Market Outlook, By Dental (2019-2028) (US $MN)
Table 27 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)
Table 28 Global Platelet Rich Plasma Market Outlook, By Ulcer Healing (2019-2028) (US $MN)
Table 29 Global Platelet Rich Plasma Market Outlook, By Venous Ulcer (2019-2028) (US $MN)
Table 30 Global Platelet Rich Plasma Market Outlook, By Traumatic Ulcer (2019-2028) (US $MN)
Table 31 Global Platelet Rich Plasma Market Outlook, By Diabetic Ulcer (2019-2028) (US $MN)
Table 32 Global Platelet Rich Plasma Market Outlook, By Pyoderma Gangrenosum Ulcer (2019-2028) (US $MN)
Table 33 Global Platelet Rich Plasma Market Outlook, By Trophic Ulcer (2019-2028) (US $MN)
Table 34 Global Platelet Rich Plasma Market Outlook, By Vasculitic Ulcer (2019-2028) (US $MN)
Table 35 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Surgery (2019-2028) (US $MN)
Table 36 Global Platelet Rich Plasma Market Outlook, By Neurosurgery (2019-2028) (US $MN)
Table 37 Global Platelet Rich Plasma Market Outlook, By General Surgery (2019-2028) (US $MN)
Table 38 Global Platelet Rich Plasma Market Outlook, By Dentistry (2019-2028) (US $MN)
Table 39 Global Platelet Rich Plasma Market Outlook, By Cardiac Muscle Injury (2019-2028) (US $MN)
Table 40 Global Platelet Rich Plasma Market Outlook, By Nerve Injury (2019-2028) (US $MN)
Table 41 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)
Table 42 Global Platelet Rich Plasma Market Outlook, By Aesthetics (2019-2028) (US $MN)
Table 43 Global Platelet Rich Plasma Market Outlook, By Others Application (2019-2028) (US $MN)
Table 44 Global Platelet Rich Plasma Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2019-2028) (US $MN)
Table 45 Global Platelet Rich Plasma Market Outlook, By Oral and Maxillofacial Surgery (2019-2028) (US $MN)
Table 46 Global Platelet Rich Plasma Market Outlook, By Periodontal Surgery (2019-2028) (US $MN)
Table 47 Global Platelet Rich Plasma Market Outlook, By Urology (2019-2028) (US $MN)
Table 48 Global Platelet Rich Plasma Market Outlook, By Cardiothoracic Surgery (2019-2028) (US $MN)
Table 49 Global Platelet Rich Plasma Market Outlook, By Growth Factor Molecules (2019-2028) (US $MN)
Table 50 Global Platelet Rich Plasma Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2019-2028) (US $MN)
Table 51 Global Platelet Rich Plasma Market Outlook, By Vascular Endothelial Growth Factor (VEGF) (2019-2028) (US $MN)
Table 52 Global Platelet Rich Plasma Market Outlook, By Epidermal Growth Factor (EGF) (2019-2028) (US $MN)
Table 53 Global Platelet Rich Plasma Market Outlook, By Fibroblast Growth Factor-2 (FGF-2) (2019-2028) (US $MN)
Table 54 Global Platelet Rich Plasma Market Outlook, By Insulin-like Growth Factor (IGF) (2019-2028) (US $MN)
Table 55 Global Platelet Rich Plasma Market Outlook, By End User (2019-2028) (US $MN)
Table 56 Global Platelet Rich Plasma Market Outlook, By Hospitals & Clinics (2019-2028) (US $MN)
Table 57 Global Platelet Rich Plasma Market Outlook, By Academic & Research Institutes (2019-2028) (US $MN)
Table 58 Global Platelet Rich Plasma Market Outlook, By Orthopedic Clinics (2019-2028) (US $MN)
Table 59 Global Platelet Rich Plasma Market Outlook, By Cosmetic/Dermatology/Trichology Clinics (2019-2028) (US $MN)
Table 60 Global Platelet Rich Plasma Market Outlook, By Physician's office/Private Practice (2019-2028) (US $MN)
Table 61 Global Platelet Rich Plasma Market Outlook, By Ophthalmic Clinics (2019-2028) (US $MN)
Table 62 Global Platelet Rich Plasma Market Outlook, By Sales Channel (2019-2028) (US $MN)
Table 63 Global Platelet Rich Plasma Market Outlook, By Manufacturer/Distributor/Service Provider (2019-2028) (US $MN)
Table 64 Global Platelet Rich Plasma Market Outlook, By Aftermarket (2019-2028) (US $MN)
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
'
